NewcelX Ltd.NCEL

$3.31+0.16 (+5.08%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$1M

Micro-cap

-100%

2021 — today

10-Year Price

-100%

2021 — today

52-Week Range

$1.88$29.00

Current $3.31· 5%

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovative treatments, utilizing both cell-based and small-molecule approaches, to address challenging neurodegenerative and metabolic diseases.

Valuation in context

P/E ratio

-0.1

N/A

Not meaningful — company is unprofitable

P/B ratio

0.5

Around average

Around the 10-year average

FCF Yield

-478.9%

Near historic low

Near historic low — last 10 years

Free · No credit card needed

Get alerted when NCEL is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.